Cyclo Therapeutics (NASDAQ:CYTH) Trading Down 2.1%
Cyclo Therapeutics (NASDAQ:CYTH) Trading Down 2.1%
Cyclo Therapeutics, Inc. (NASDAQ:CYTH – Get Rating) dropped 2.1% on Monday . The stock traded as low as $1.84 and last traded at $1.90. Approximately 122,319 shares were traded during mid-day trading, an increase of 169% from the average daily volume of 45,420 shares. The stock had previously closed at $1.94.
Cyclo Therapeutics Stock Performance
The firm has a 50-day simple moving average of $1.65 and a two-hundred day simple moving average of $1.96. The company has a market capitalization of $16.12 million, a price-to-earnings ratio of -1.20 and a beta of -0.53.
Get Cyclo Therapeutics alerts:
Hedge Funds Weigh In On Cyclo Therapeutics
An institutional investor recently raised its position in Cyclo Therapeutics stock. Renaissance Technologies LLC grew its stake in Cyclo Therapeutics, Inc. (NASDAQ:CYTH – Get Rating) by 14.3% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 75,787 shares of the company's stock after buying an additional 9,487 shares during the quarter. Renaissance Technologies LLC owned 1.17% of Cyclo Therapeutics worth $240,000 as of its most recent filing with the SEC. Institutional investors own 4.77% of the company's stock.
Cyclo Therapeutics Company Profile
(Get Rating)
Cyclo Therapeutics, Inc, a clinical stage biotechnology company, develops cyclodextrin-based products for the treatment of various diseases. Its lead drug candidate is Trappsol Cyclo, an orphan drug, which is Phase III clinical trials for the treatment of Niemann-Pick Type C disease. The company also develops Trappsol Cyclo for the treatment of Alzheimer's disease.
Cyclo Therapeutics, Inc. (NASDAQ:CYTH – Get Rating) dropped 2.1% on Monday . The stock traded as low as $1.84 and last traded at $1.90. Approximately 122,319 shares were traded during mid-day trading, an increase of 169% from the average daily volume of 45,420 shares. The stock had previously closed at $1.94.
週期治療, 公司. (NASDAQ: CYTH — 獲得評級) 下降 2.1% 在星期一.該股價低至 1.84 美元，最後交易價為 1.90 美元。在日間交易期間成交約 122,319 股股份，較每日 45,420 股的平均成交量增加 169%。該股票之前已收盤於 1.94 美元。
Cyclo Therapeutics Stock Performance
循環治療股票表現
The firm has a 50-day simple moving average of $1.65 and a two-hundred day simple moving average of $1.96. The company has a market capitalization of $16.12 million, a price-to-earnings ratio of -1.20 and a beta of -0.53.
該公司擁有 50 天的簡單移動平均線 1.65 美元和 200 天的簡單移動平均線 1.96 美元。該公司的市值為 1612 萬美元，價格與收益比為 -1.20，測試版為 -0.53。
Get Cyclo Therapeutics alerts:
取得 循環治療 警報：
Hedge Funds Weigh In On Cyclo Therapeutics
對沖基金權衡循環治療
An institutional investor recently raised its position in Cyclo Therapeutics stock. Renaissance Technologies LLC grew its stake in Cyclo Therapeutics, Inc. (NASDAQ:CYTH – Get Rating) by 14.3% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 75,787 shares of the company's stock after buying an additional 9,487 shares during the quarter. Renaissance Technologies LLC owned 1.17% of Cyclo Therapeutics worth $240,000 as of its most recent filing with the SEC. Institutional investors own 4.77% of the company's stock.
一家機構投資者最近提出了其在 Cyclo 治療股票中的地位。根據最近在 SEC 提交的文件，文藝復興技術有限責任公司在第一季度將其在 Cyclo 治療藥物公司（NASDAQ：CYTH-獲得評級）的股份增長了 14.3％。該公司在本季度額外購買 9,487 股股票後擁有該公司股票的 75,787 股。文藝復興技術有限責任公司擁有 1.17％ 的 Cyclo 治療，價值 240,000 美元，截至最近在美國證券交易委員會提交的文件。機構投資者擁有公司股票的 4.77%。
Cyclo Therapeutics Company Profile
循環治療公司簡介
(Get Rating)
(取得評分)
Cyclo Therapeutics, Inc, a clinical stage biotechnology company, develops cyclodextrin-based products for the treatment of various diseases. Its lead drug candidate is Trappsol Cyclo, an orphan drug, which is Phase III clinical trials for the treatment of Niemann-Pick Type C disease. The company also develops Trappsol Cyclo for the treatment of Alzheimer's disease.
Cyclo Therapetics, Inc 是一家臨床階段生物技術公司，開發出基於環糊精素的產品，用於治療各種疾病。其主要候選藥物是特拉普索爾 Cyclo，這是一種孤兒藥物，這是用於治療 C 型尼曼匹克疾病的 III 期臨床試驗。該公司還開發了用於治療阿爾茨海默氏病的特拉普索爾 Cyclo。
譯文內容由第三人軟體翻譯。
風險及免責聲明
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧